The Gnotobiotic Research Platform is open for business
The RI-MUHC and McGill University form a hub to integrate microbiome research activities
Two RI-MUHC trainees win McGill MedStar awards
Congratulations to Daniela Massierer and Mohamed Abdulhakem Omar Shengir!
McGill International TB Centre receives $17.2 M for clinical trials and clinical research on tuberculosis
RI-MUHC researcher Dick Menzies leads international network to fight TB
FALL 2020 CIHR COMPETITION RESULTS
RI-MUHC teams received $6.9 million in project funding and $2 million more for COVID-19 research
Saliva samples for COVID-19 testing: as good as nasopharyngeal swabs, but cheaper
New meta-analysis of 37 studies and over 7,000 paired saliva and nasopharyngeal swab samples
Could a different testing strategy reduce healthcare workers’ isolation after unprotected exposure to a confirmed case of COVID-19?
RI-MUHC study suggests appropriate...
The RI-MUHC leads new clinical trial of COVID-19 treatment for hospitalized patients
Phase 2 study tests LAU-7b, a Canadian drug with dual antiviral and inflammation-controlling effects
Driving Personalized Medicine: The 2020 RI-MUHC Annual Report is online!
An invitation from Dr. Miguel Burnier Jr.
What do we know about sleep apnea, pregnancy and gestational diabetes?
RI-MUHC researchers find link that may lead to better health for mother and baby
Stem cells are the marrow of the TB pandemic, which still kills one person every 22 seconds
A new study finds that not only can stem cells be targeted for protective vaccination, but they can also ...